Conversely, increased FOXP3 expression has been reported in pancreatic adenocarcinoma [5], melanoma [6-8], hepatocellular carcinoma [9], leukemia [10], bladder cancer [11], thyroid carcinoma [12] and cervical cancer [13], with no expression in corresponding normal tissue. This evidence concerns the gene FOXP3 and pancreatic adenocarcinoma.